Skip to main content
. 2023 Apr 28;11:e15242. doi: 10.7717/peerj.15242

Table 1. Characteristics of 88 patients.

Patient characteristics Moderate differentiation (60) Poor differentiation (28)
Age (Year) 60.2 ± 8.1 60.4 ± 9.1
Lobe location
Right upper lobe N (%) 17(28.3) 9(32.1)
Right middle lobe N (%) 2(3.3) 4(14.3)
Right lower lobe N (%) 14(23.4) 4(14.3)
Left upper lobe N (%) 19(31.7) 7(25.0)
Left lower lobe N (%) 8(13.3) 4(14.3)
Gender
Male N (%) 28(46.7) 16(57.1)
Female N (%) 32(53.3) 12(42.9)
Smoking
Yes N (%) 19(31.7) 17(60.7)
No N (%) 41(68.3) 11(39.3)
CEA
>5ng/ml N (%) 19(31.7) 15(53.6)
<5ng/ml N (%) 41(68.3) 13(46.4)
Lymph node metastasis
Yes N (%) 12(20.0) 11(39.3)
No N (%) 48(80.0) 17(60.7)
Clinical T descriptor
T1
T1a N (%) 1(1.7) 0
T1b N (%) 17(28.3) 7(25.0)
T1c N (%) 30(50.0) 12(42.9)
T2
T2a N (%) 7(11.7) 5(17.8)
T2b N (%) 5(8.3) 4(14.3)

Notes.

Note—Age is shown as means ± standard deviations. The remaining data are numbers of patients.

CEA
carcinoembryonic antigen